{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:39:50Z","timestamp":1761676790050,"version":"build-2065373602"},"reference-count":89,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["602904"],"award-info":[{"award-number":["602904"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Cost- and time-intensive porcine translational disease models offer great opportunities to test drugs and therapies for pathological cardiac hypertrophy and can be supported by porcine cell culture models that provide further insights into basic disease mechanisms. Cardiac progenitor cells (CPCs) residing in the adult heart have been shown to differentiate in vitro into cardiomyocytes and could contribute to cardiac regeneration. Therefore, it is important to evaluate their changes on the cellular level caused by disease. We successfully isolated Isl1+Sca1+cKit+ porcine CPCs (pCPCs) from pig hearts and stimulated them with endothelin-1 (ET-1) and angiotensin II (Ang II) in vitro. We also performed a cardiac reprogramming transfection and tested the same conditions. Our results show that undifferentiated Isl1+Sca1+cKit+ pCPCs were significantly upregulated in GATA4, MEF2c, and miR-29a gene expressions and in BNP and MCP-1 protein expressions with Ang II stimulation, but they showed no significant changes in miR-29a and MCP-1 when stimulated with ET-1. Differentiated Isl1+Sca1+cKit+ pCPCs exhibited significantly higher levels of MEF2c, GATA4, miR-29a, and miR-21 as well as Cx43 and BNP with Ang II stimulation. pMx-MGT-transfected Isl1+Sca1+cKit+ pCPCs showed significant elevations in MEF2c, GATA4, and BNP expressions when stimulated with ET-1. Our model demonstrates that in vitro stimulation leads to successful Isl1+Sca1+cKit+ pCPC hypertrophy with upregulation of cardiac remodeling associated genes and profibrotic miRNAs and offers great possibilities for further investigations of disease mechanisms and treatment.<\/jats:p>","DOI":"10.3390\/cells8111416","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T04:07:07Z","timestamp":1573531627000},"page":"1416","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1+Sca-1+c-kit+ Porcine Cardiac Progenitor Cells In Vitro"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3855-7643","authenticated-orcid":false,"given":"Katrin","family":"Zlabinger","sequence":"first","affiliation":[{"name":"Medical University of Vienna, Department of Cardiology, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9819-0361","authenticated-orcid":false,"given":"Andreas","family":"Spannbauer","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Department of Cardiology, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-1525","authenticated-orcid":false,"given":"Denise","family":"Traxler","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Department of Cardiology, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5178-9967","authenticated-orcid":false,"given":"Alfred","family":"Gugerell","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Department of Cardiology, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Lukovic","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Department of Cardiology, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Winkler","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Department of Cardiology, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1426-6670","authenticated-orcid":false,"given":"Julia","family":"Mester-Tonczar","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Department of Cardiology, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4641-7202","authenticated-orcid":false,"given":"Bruno","family":"Podesser","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Department of Biomedical Research, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-2107","authenticated-orcid":false,"given":"Mariann","family":"Gy\u00f6ngy\u00f6si","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Department of Cardiology, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.RES.0000077012.11088.BC","article-title":"Phenotyping Hypertrophy","volume":"92","author":"Dorn","year":"2003","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/hrt.2004.042473","article-title":"Left ventricular hypertrophy in hypertension: Its arrhythmogenic potential","volume":"91","author":"Kahan","year":"2005","journal-title":"Heart"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/FJC.0000000000000126","article-title":"Targeting cardiac hypertrophy: Toward a causal heart failure therapy","volume":"64","author":"Bisping","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.biocel.2008.02.020","article-title":"Molecular regulation of cardiac hypertrophy","volume":"40","author":"Barry","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"239ps6","DOI":"10.1126\/scitranslmed.3008921","article-title":"Human stem cells for modeling heart disease and for drug discovery","volume":"6","author":"Matsa","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.yjmcc.2008.05.002","article-title":"Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis","volume":"45","author":"Perino","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/CIRCRESAHA.112.266510","article-title":"Islet1 derivatives in the heart are of both neural crest and second heart field origin","volume":"110","author":"Engleka","year":"2012","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5720758","DOI":"10.1155\/2016\/5720758","article-title":"Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives","volume":"2016","author":"Marketou","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_11","first-page":"1242","article-title":"Developmental origin and lineage plasticity of endogenous cardiac stem cells","volume":"143","author":"Santini","year":"2016","journal-title":"Dev. Camb. Engl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1534-5807(03)00363-0","article-title":"Isl1 Identifies a Cardiac Progenitor Population that Proliferates Prior to Differentiation and Contributes a Majority of Cells to the Heart","volume":"5","author":"Cai","year":"2003","journal-title":"Dev. Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ncb1906","article-title":"A Regulatory Pathway Involving Notch1\/\u03b2-Catenin\/Isl1 Determines Cardiac Progenitor Cell Fate","volume":"11","author":"Kwon","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"ref_14","first-page":"3931","article-title":"Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development","volume":"131","author":"Dodou","year":"2004","journal-title":"Dev. Camb. Engl."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1073\/pnas.94.14.7543","article-title":"Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload","volume":"94","author":"Herzig","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1161\/01.CIR.96.11.3943","article-title":"cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction","volume":"96","author":"Hasegawa","year":"1997","journal-title":"Circulation"},{"key":"ref_17","first-page":"4947","article-title":"Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene","volume":"14","author":"Molkentin","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1128\/MCB.16.8.4524","article-title":"Distinct gene expression patterns in skeletal and cardiac muscle are dependent on common regulatory sequences in the MLC1\/3 locus","volume":"16","author":"McGrew","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"ref_19","first-page":"7517","article-title":"The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells","volume":"14","author":"Ip","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/bj3220393","article-title":"Regulation of the rat cardiac troponin I gene by the transcription factor GATA-4","volume":"322","author":"Murphy","year":"1997","journal-title":"Biochem. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-1119(96)00738-X","article-title":"The cardiac-muscle specific enhancer-promoter of slow\/cardiac troponin C binds HMG-2","volume":"187","author":"Montgomery","year":"1997","journal-title":"Gene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1093\/emboj\/16.18.5687","article-title":"The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors","volume":"16","author":"Durocher","year":"1997","journal-title":"EMBO J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17772","DOI":"10.1016\/S0021-9258(17)32374-8","article-title":"Regulation of rat brain natriuretic peptide transcription. A potential role for GATA-related transcription factors in myocardial cell gene expression","volume":"269","author":"Thuerauf","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"23807","DOI":"10.1074\/jbc.M302719200","article-title":"GATA-4 Is a Nuclear Mediator of Mechanical Stretch-activated Hypertrophic Program","volume":"278","author":"Pikkarainen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"30245","DOI":"10.1074\/jbc.M102174200","article-title":"The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo","volume":"276","author":"Liang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_26","unstructured":"Willis, M.S., Homeister, J.W., and Stone, J.R. (2014). Chapter 4\u2014The Pathophysiology of Cardiac Hypertrophy and Heart Failure. Cellular and Molecular Pathobiology of Cardiovascular Disease, Academic Press."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbrc.2009.07.147","article-title":"The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling","volume":"388","author":"Collao","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"91068","DOI":"10.1172\/jci.insight.91068","article-title":"Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface","volume":"2","author":"Wei","year":"2017","journal-title":"JCI Insight 2"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-physiol-030212-183737","article-title":"Functions of microRNAs in cardiovascular biology and disease","volume":"75","author":"Hata","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","article-title":"MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice","volume":"119","author":"Callis","year":"2009","journal-title":"J. Clin. Invest."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1073\/pnas.0811371106","article-title":"miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy","volume":"106","author":"Lin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"Sutherland","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/CIRCULATIONAHA.108.814145","article-title":"MicroRNA-320 is involved in the regulation of cardiac ischemia\/reperfusion injury by targeting heat-shock protein 20","volume":"119","author":"Ren","year":"2009","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.20101547","article-title":"miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes","volume":"208","author":"Qian","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCRESAHA.108.193102","article-title":"Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes","volume":"104","author":"Rane","year":"2009","journal-title":"Circ. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2013.09.041","article-title":"Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy","volume":"63","author":"Roncarati","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e13323","DOI":"10.1111\/apha.13323","article-title":"miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN\/AKT\/mTOR signalling pathway and suppressing autophagy","volume":"2019","author":"Shi","year":"2019","journal-title":"Acta Physiol. Oxf. Engl."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.lfs.2012.02.006","article-title":"ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy","volume":"91","author":"Adiarto","year":"2012","journal-title":"Life Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.96.5.1593","article-title":"Angiotensin II Increases Tissue Endothelin and Induces Vascular Hypertrophy","volume":"96","author":"Moreau","year":"1997","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000112596.06954.00","article-title":"Endothelin-1\u2013Induced Cardiac Hypertrophy Is Inhibited by Activation of Peroxisome Proliferator\u2013Activated Receptor-\u03b1 Partly Via Blockade of c-Jun NH2-Terminal Kinase Pathway","volume":"109","author":"Miyauchi","year":"2004","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Bupha-Intr, T., Haizlip, K.M., and Janssen, P.M.L. (2012). Role of Endothelin in the Induction of Cardiac Hypertrophy In Vitro. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043179"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","article-title":"Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts","volume":"40","author":"Gray","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cellsig.2011.02.007","article-title":"Cell signalling pathways for the regulation of GATA4 transcription factor: Implications for cell growth and apoptosis","volume":"23","author":"Suzuki","year":"2011","journal-title":"Cell. Signal."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.CIR.103.5.730","article-title":"Pressure overload increases GATA4 binding activity via endothelin-1","volume":"103","author":"Hautala","year":"2001","journal-title":"Circulation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13721","DOI":"10.1074\/jbc.275.18.13721","article-title":"Phosphorylation of GATA-4 is involved in alpha 1-adrenergic agonist-responsive transcription of the endothelin-1 gene in cardiac myocytes","volume":"275","author":"Morimoto","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pbiomolbio.2008.02.026","article-title":"The slow force response to stretch in atrial and ventricular myocardium from human heart: Functional relevance and subcellular mechanisms","volume":"97","author":"Khafaga","year":"2008","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.3892\/mmr.2016.5574","article-title":"MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cvr\/cvx222","article-title":"Meox1 accelerates myocardial hypertrophic decompensation through Gata4","volume":"114","author":"Lu","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.stemcr.2018.01.016","article-title":"Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes","volume":"10","author":"Ovchinnikova","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Aggarwal, P., Turner, A., Matter, A., Kattman, S.J., Stoddard, A., Lorier, R., Swanson, B.J., Arnett, D.K., and Broeckel, U. (2014). RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108051"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pharmthera.2013.10.007","article-title":"Small and large animal models in cardiac contraction research: Advantages and disadvantages","volume":"141","author":"Janssen","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCRESAHA.116.305547","article-title":"Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming","volume":"116","author":"Wang","year":"2015","journal-title":"Circ. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.bbadis.2013.07.003","article-title":"Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease","volume":"1832","author":"Sergeeva","year":"2013","journal-title":"Biochim. Biophys. Acta BBA-Mol. Basis Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e002423","DOI":"10.1161\/JAHA.115.002423","article-title":"Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events","volume":"4","author":"Ulvila","year":"2015","journal-title":"J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1073\/pnas.0500169102","article-title":"Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure","volume":"102","author":"Urbanek","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Davis, D.R., Zhang, Y., Smith, R.R., Cheng, K., Terrovitis, J., Malliaras, K., Li, T.-S., White, A., Makkar, R., and Marb\u00e1n, E. (2009). Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007195"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature08191","article-title":"Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages","volume":"460","author":"Bu","year":"2009","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1089\/scd.2014.0197","article-title":"Sca-1+ Cardiac Progenitor Cells and Heart-Making: A Critical Synopsis","volume":"23","author":"Valente","year":"2014","journal-title":"Stem Cells Dev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7471582","DOI":"10.1155\/2017\/7471582","article-title":"Cardiac Progenitor Cells and the Interplay with Their Microenvironment","volume":"2017","author":"Mauretti","year":"2017","journal-title":"Stem Cells Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","article-title":"Human cardiac stem cells","volume":"104","author":"Bearzi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Al-Maqtari, T., Hong, K.U., Vajravelu, B.N., Moktar, A., Cao, P., Moore, J.B., and Bolli, R. (2017). Transcription factor-induced activation of cardiac gene expression in human c-kit+ cardiac progenitor cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174242"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.stemcr.2019.01.017","article-title":"Calpain Inhibition Restores Autophagy and Prevents Mitochondrial Fragmentation in a Human iPSC Model of Diabetic Endotheliopathy","volume":"12","author":"Ong","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_67","first-page":"2775","article-title":"Endothelin signaling activates Mef2c expression in the neural crest through a MEF2C-dependent positive-feedback transcriptional pathway","volume":"142","author":"Hu","year":"2015","journal-title":"Dev. Camb. Engl."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1038\/cddis.2010.56","article-title":"MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV\/HIV neurological disease","volume":"1","author":"Yelamanchili","year":"2010","journal-title":"Cell Death Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2017.12.005","article-title":"Angiotensin II receptor blocker valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21 expression in diabetic nephropathy mice","volume":"472","author":"Wang","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","article-title":"Role of miR-21 in the pathogenesis of atrial fibrosis","volume":"107","author":"Adam","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2016.6669","article-title":"MicroRNA-21 mediates angiotensin II-induced liver fibrosis by activating NLRP3 Inflammasome\/IL-1\u03b2 axis via targeting Smad7 and Spry1","volume":"27","author":"Ning","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1242\/dev.132910","article-title":"Building and re-building the heart by cardiomyocyte proliferation","volume":"143","author":"Foglia","year":"2016","journal-title":"Development"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCRESAHA.116.310058","article-title":"Cardiomyocyte Proliferation","volume":"120","author":"Yutzey","year":"2017","journal-title":"Circ. Res."},{"key":"ref_74","first-page":"H2183","article-title":"Cardiomyocyte DNA synthesis and binucleation during murine development","volume":"271","author":"Soonpaa","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/01.ATV.19.6.1518","article-title":"Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice","volume":"19","author":"Lindsey","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/01.CIR.102.11.1315","article-title":"Monocyte Chemoattractant Protein-1 is upregulated in rats with volume-overload congestive heart failure","volume":"102","author":"Wang","year":"2000","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/CS20080581","article-title":"Role of MCP-1 in cardiovascular disease: Molecular mechanisms and clinical implications","volume":"117","author":"Niu","year":"2009","journal-title":"Clin. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1291\/hypres.29.743","article-title":"Role of NAD(P)H oxidase and its regulation in chronic hypertension","volume":"29","author":"Iwai","year":"2006","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mcna.2009.02.015","article-title":"Oxidative stress and hypertension","volume":"93","author":"Harrison","year":"2009","journal-title":"Med. Clin. N. Am."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, Immunity and Hypertension","volume":"57","author":"Harrison","year":"2011","journal-title":"Hypertension"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"833","DOI":"10.5551\/jat.27292","article-title":"Angiotensin II Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4","volume":"22","author":"Matsuda","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.RES.87.5.346","article-title":"Role of Gap Junctions in Cardiac Conduction and Development","volume":"87","year":"2000","journal-title":"Circ. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvn203","article-title":"Fate of connexin43 in cardiac tissue harbouring a disease-linked connexin43 mutant","volume":"80","author":"Manias","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cardiores.2003.12.010","article-title":"Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis","volume":"62","author":"Kostin","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.ehj.2004.08.007","article-title":"Regulation of myocardial connexins during hypertrophic remodelling","volume":"25","author":"Teunissen","year":"2004","journal-title":"Eur. Heart J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"H806","DOI":"10.1152\/ajpheart.01058.2008","article-title":"Temporal changes in expression of connexin 43 after load-induced hypertrophy in vitro","volume":"296","author":"Haizlip","year":"2009","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/abbs\/gmy090","article-title":"Angiotensin II upregulates fibroblast-myofibroblast transition through Cx43-dependent CaMKII and TGF-\u03b21 signaling in neonatal rat cardiac fibroblasts","volume":"50","author":"Cao","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0735-1097(98)00317-9","article-title":"Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes","volume":"32","author":"Dodge","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"41294","DOI":"10.1074\/jbc.M304785200","article-title":"Endothelin-1 Decreases Gap Junctional Intercellular Communication by Inducing Phosphorylation of Connexin 43 in Human Ovarian Carcinoma Cells","volume":"278","author":"Spinella","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/11\/1416\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:33:15Z","timestamp":1760189595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/11\/1416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,9]]},"references-count":89,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["cells8111416"],"URL":"https:\/\/doi.org\/10.3390\/cells8111416","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2019,11,9]]}}}